O'hara Caroline M
Division of Healthcare Quality Promotion, Centers for Disease Control, Atlanta, GA 30333, USA.
Clin Microbiol Rev. 2005 Jan;18(1):147-62. doi: 10.1128/CMR.18.1.147-162.2005.
Identification of gram-negative bacilli, both enteric and nonenteric, by conventional methods is not realistic for clinical microbiology laboratories performing routine cultures in today's world. The use of commercial kits, either manual or automated, to identify these organisms is a common practice. The advent of rapid or "spot" testing has eliminated the need for some commonly isolated organisms to be identified with the systems approach. Commercially available systems provide more in-depth identification to the species level as well as detect new and unusual strains. The answers obtained from these systems may not always be correct and must be interpreted with caution. The patient demographics, laboratory workload and work flow, and technologist's skill levels should dictate the system of choice. Cost considerations introduce another variable into the equation affecting choice. Each system has its own strengths and weaknesses, and each laboratory must decide on the level of sophistication that fulfills its particular needs.
对于当今世界进行常规培养的临床微生物实验室而言,采用传统方法鉴定革兰氏阴性杆菌(包括肠道菌和非肠道菌)并不现实。使用商业试剂盒(无论是手动还是自动的)来鉴定这些微生物是一种常见做法。快速或“即时”检测的出现,使得一些常见分离菌无需采用系统方法进行鉴定。市售系统能够提供更深入的种水平鉴定,还能检测新的和不常见的菌株。从这些系统获得的答案不一定总是正确的,必须谨慎解读。患者人口统计学信息、实验室工作量和工作流程以及技术人员的技能水平应决定所选择的系统。成本考量为影响选择的因素引入了另一个变量。每个系统都有其自身的优缺点,每个实验室都必须决定满足其特定需求的复杂程度。